Diagnosis of posttransplant lymphoproliferative disorder in solid organ transplant recipients bcsh and bts guidelines. The majority of cases in the uk are derived from b lymphocytes and are. Posttransplantation lymphoproliferative disorder and okt3 nejm. Of these, posttransplant lymphoproliferative disorder ptld is a serious complication of solid organ transplantation, occurring at an increased risk compared with both the general population and patients on transplant waiting lists 1. Definition posttransplant lymphoproliferative disorder ptld is a lymphoid proliferation or lymphoma that develops as a consequence of immunosupression in a recipient of a solid organ or bone marrow allograft. Intrathecal rituximab for ebvassociated posttransplant. The majority of ptld is of bcell origin and associated with epsteinbarr virus ebv. Risk factors and prognosis melissa schapiro, md september 1, 2011 primary goal of the study was to identify risk factors. Post transplant lymphoproliferative disorder ptld is a rare complication of solid organ transplantation. Posttransplantation lymphoproliferative disorders pptlds are defined as lymphomas that occur after transplantation fig. Post transplant lymphoproliferative disorder ptld after solid organ or hematopoietic stem cell transplantation in children is a serious complication that has been responsible for high mortality. The posttransplant lymphoproliferative disorders ptld are a group of potentially lifethreatening conditions that affect patients who have had an organ or bone marrow transplant ptld occurs because the immune system of these patients is weakened to allow them to accept the newly transplanted organ or bone marrow.
Some of these bcells may undergo mutations which will render them malignant, giving rise to a lymphoma. Posttransplant lymphoproliferative disorder ptld is a complication that can develop after an organ transplant or after an allogeneic stem cell transplant. A short presentation of ptld in solid organ transplants for the internist and general nephrologists. Primary central nervous system post transplant lymphoproliferative disorder pcnsptld represents a spectrum of diseases characterized by abnormal proliferation of lymphoid tissues encountered in patients who have received solid organ or bone ma.
The findings of posttransplant lymphoproliferative disorder ptld in this case are indistinguishable from traditional nonhodgkin lymphoma nhl in an immunocompetent patient. Posttransplant lymphoproliferative disorders ptld are a serious complication after solid organ or allogeneic hematopoietic stem cell transplantation and include a range of diseases from benign proliferations to malignant lymphomas. Management of posttransplant lymphoproliferative disorders. Posttransplant lymphoproliferative disease ptld is an uncommon condition occurring in people who have been given immunosuppressive therapy medicine that limits the activity of the immune system after receiving an organ transplant. Late onset post transplant lymphoproliferative disorder. Post transplant lymphoproliferative disorder ptld is a lifethreatening complication after hematopoietic stem cell or solid organ transplantation.
Posttransplant lymphoproliferative disorders nature. Posttransplantation lymphoproliferative disorder ptld is an uncommon but serious complication of immunosuppressive therapy following solid organ transplantation. Posttransplant lymphoproliferative disorder ptld is a recognized complication exclusive to solid organ transplant recipients and carries a high mortality. Impact of posttransplant lymphoproliferative disorder. Treatment of posttransplant lymphoproliferative disorder. Post transplant lymphoproliferative disorder ptld, also referred as post transplant lymphoproliferation disorder, represents a variety of conditions ranging from lymphoid hyperplasia to malignancy, included in the who classification of tumors o. Posttransplant lymphoproliferative disorder clinical gate. Prophylaxis against transplant rejection and graftversushost disease is often immunosuppressive and can increase the risk of lymphoproliferative disease. Posttransplant lymphoproliferative disorder radiology. Risk factors for ptld include type and duration of immunosuppression, age of the patient, and the type of. Late onset post transplant lymphoproliferative disorder ptld a cause for prolonged fever in a patient with biliary anastomotic stricture need to think beyond cholangitis ashok choudhury, apurva pande, binit sureka and chaggan bihari sharma department of hepatology and transplant medicine, institute of liver and biliary sciences, india. Posttransplant lymphoproliferative disorder ptld is a potentially fatal.
However, a major drawback of the chronically immunosuppressed status of these individuals is the development of a potentially fatal post transplant lymphoproliferative disorder ptld in up to 20% of transplant recipients. Posttransplantation lymphoproliferative disorder ptld is a recognized and extremely morbid complication of solid organ transplantation, but central nervous system involvement, particularly in isolation, is rare. Posttransplant lymphoproliferative disorders ptld are lymphoid andor. Posttransplant lymphoproliferative disorder ptld is the name given to a bcell proliferation due to therapeutic immunosuppression after organ transplantation. Posttransplant lymphoproliferative disorder is the name given to a bcell proliferation due to therapeutic immunosuppression after organ transplantation. Hodgkin disease nonhodgkin lymphoma histiocytosis x benign reactive lymphoproliferative disorders including posttransplantation lymphoproliferative disorder ptld plasma cell neoplasms cutaneous tcell lymphoma mostly in heart, pancreas and bone marr. It can be thought of as one of the immunodeficiencyassociated cns lymphomas 3 for a general discussion of systemic disease. Purpose posttransplantation lymphoproliferative disorder ptld is.
The major risk factor for ptld in solid organ transplantation is the degree of immunosuppression. Posttransplant lymphoproliferative disorder of the. Ptld represents a heterogeneous group of lymphoproliferative diseases. To evaluate the incidence of posttransplant lymphoproliferative disease ptld and the risk factors and the impact of this complication on survival outcomes in a large cohort of liver transplant recipients at a single institution. Posttransplant lymphoproliferative disease ncbi nih. Posttransplant lymphoproliferative disorder ptld is a lifethreatening complication after hematopoietic stem cell or solid organ transplantation. Posttransplant lymphoproliferative disorders in liver. Post transplant lymphoproliferative disorder ptld is a clearly recognized and potentially life threatening complication after solid organ or bone marrow transplantation. Jan 12, 2017 posttransplant lymphoproliferative disorder ptld is a wellrecognized complication of immunosuppressive therapy following solidorgan transplantation. Post transplant lymphoproliferative disease ptld is an uncommon condition occurring in people who have been given immunosuppressive therapy medicine that limits the activity of the immune system after receiving an organ transplant. Posttransplant lymphoproliferative disorders mayo clinic. Posttransplant lymphoproliferative disorder ptld is a wellrecognized complication of immunosuppressive therapy following solidorgan transplantation. Posttransplant lymphoproliferative disorders ptlds are lymphomas that can develop after a transplant.
In healthy individuals ebv causes a self limited infectious mononucleosis syndrome. Recipients of solidorgan or allogeneic hematopoietic stemcell transplants have an increased risk of cancers related to immunosuppression and the epsteinbarr virus ebv in particular, lymphomas. Posttransplant lymphoproliferative disease ptld is a complication of transplantation in which there is uncontrolled growth of lymphocytes. Post transplant lymphoproliferative disorders ptld are lymphoid andor plasmacytic proliferations that occur in the setting of solid organ or allogeneic hematopoietic cell transplantation as a result of immunosuppression. Jan 28, 2016 post transplant lymphoproliferative disorders ptlds are a group of conditions that involve uncontrolled proliferation of lymphoid cells as a consequence of extrinsic immunosuppression after. Management of posttransplant lymphoproliferative disorder. Sep 08, 2016 lymphoproliferative disorders lpds can be parsed into the following 6 categories. They are among the most serious and potentially fatal complications of. Ptld can develop in people who are taking medicines to dampen their immune system in order to prevent rejection after an organ transplant or an allogeneic donor stem cell transplant. Posttransplant lymphoproliferative disease following. Posttransplantation lymphoproliferative disorder in the epsteinbarr virusnaive lung transplant recipient. Posttransplant lymphoproliferative disorder wikipedia.
Posttransplant lymphoproliferative disorders ptld are lymphoid andor plasmacytic proliferations that occur in the setting of solid organ or allogeneic hematopoietic cell transplantation as a result of immunosuppression. In some patients, the malignant cell clone can become the dominant proliferating cell type, leading to frank lymphoma, a group of. How i treat posttransplant lymphoproliferative disorders blood. We describe the case of a transplant recipient who presented with rapidly progressive cranial nerve palsies due to ptld that originated in the sphenoid sinus. The post transplant lymphoproliferative disorders ptld are a group of potentially lifethreatening conditions that affect patients who have had an organ or bone marrow transplant. Histologic heterogeneity and lack of treatment standards have made evaluating clinical outcomes in specific patient populations difficult.
To improve the positive predictive value of ebv viral load, different approaches have been described that combine ebv pcr with. Treatment guidelines include reduction in immunosuppression ris, radiation, rituximab, chemotherapy, and immunological agents. Ptld may also be referred to as early onset or late onset. Post transplant lymphoproliferative disorders ptld are a group of disorders that occur in patients who have immunodeficiency secondary to treatment with immunomodulator agents following either solid organ transplant sot or haematopoietic stem cell transplant hsct. Posttransplant lymphoproliferative disorders springerlink. It occurs in up to 5% of patients, depending on the type of organ transplanted and the type and duration of immunosuppressive treatment. Ptld is a relatively new disease entity that is now widely recognized. Posttransplantation lymphoproliferative disorder ptld is a challenging complication associated with organ transplantation and is usually fatal if untreated.
Feb 05, 2019 post transplant lymphoproliferative disease ptld is a complication of transplantation in which there is uncontrolled growth of lymphocytes. Posttransplantation lymphoproliferative disorder of the. Posttransplantation lymphoproliferative disorders in adults. Six patients were cleared with therapy, while the patient with grade iii agvhd merged into extensive chronic gvhd. Posttransplant lymphoproliferative disease ptld emerged in the mid1990s as.
Posttransplantation lymphoproliferative disorders solidorgan and hematopoietic stemcell transplants are widely used for various lifethreatening medical disorders. Management of posttransplant lymphoproliferative disorder in adult solid organ transplant recipients bcsh and bts guidelines. Post transplant lymphoproliferative disorders after liver. Posttransplantation lymphoproliferative disorder and okt3. May 01, 2007 renal transplant recipients carry an increased risk of developing malignancies.
They are among the most serious and potentially fatal complications of transplantation. It occurs in people whose immune systems have been intentionally suppressed due to having a solid organ transplant or. These guidelines for managing ptld were developed by the british committee for standards in haematology and the british transplantation society. These lymphoproliferative processes are clinically and morphologically heterogeneous, and are known as posttransplant lymphoproliferative disorders ptlds, which occasionally evolve into clinical lymphoma. Renal transplant recipients carry an increased risk of developing malignancies. Post transplant lymphoproliferative disorder ptld is the name given to a bcell proliferation due to therapeutic immunosuppression after organ transplantation. Post transplant lymphoproliferative disorder ptld is a recognized complication exclusive to solid organ transplant recipients and carries a high mortality. Posttransplant lymphoproliferative disorder ptld is a clearly recognized and potentially life threatening complication after solid organ or bone marrow transplantation. To test whether response to initial treatment with singleagent rituximab predicts outcome, investigators conducted a multicenter, prospective, phase ii trial involving cd20positive ptld. Solidorgan and hematopoietic stemcell transplants are widely used for various lifethreatening medical disorders.
Ebvassociated posttransplant lymphoproliferative disorder ptld is a liftthreatening. Posttransplant lymphoproliferative disorder canadian. Posttransplant lymphoproliferative disease genetic and. Post transplant lymphoproliferative disorder gs chowdhary1, malav jhala2 abstract post transplant lymphoproliferative disorders ptlds are lifethreatening complications of solidorgan transplantation and bone marrow transplantation leading to a high mortality. Lymphoproliferative means relating to proliferation rapid growth of lymphocytes. Ptld in solid organ transplant has an overall frequency of 210% and is seen relatively.
Posttransplant lymphoproliferative diseases ptld are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate solid organ or hematopoietic transplantation. The term posttransplant lymphoproliferative disorder ptld is applied to a group of lymphoproliferative disorders arising in a pharmacologically immunocompromised host after solidorgan or allogeneic stem cell transplantation. Ptld is one of the most common post transplant cancers. Posttransplant lymphoproliferative disorder ptld is the commonest cause of cancerrelated mortality postsolid organ transplant. Early onset means that a lymphoproliferative disorder develops shortly after the transplant, usually within twelve months. It comprises a spectrum of diseases ranging from infectious mononucleosis and lymphoid hyperplasia to highly aggressive lymphoma. Post transplantation lymphoproliferative disorder ptld is an uncommon but serious complication of immunosuppressive therapy following solid organ transplantation. Of these, post transplant lymphoproliferative disorder ptld is a serious complication of solid organ transplantation, occurring at an increased risk compared with both the general population and patients on transplant waiting lists 1. There are no standardized treatment strategies for ptld, though commonly used strategies include reduction of immunosuppression, chemotherapy, rituximab, radiation, and surgery. Because these disorders are rare, there are no randomized trials from which to derive optimal treatment. Posttransplantation lymphoproliferative disorders in. Primary central nervous system posttransplant lymphoproliferative disorder pcnsptld represents a spectrum of diseases characterized by abnormal proliferation of lymphoid tissues encountered in patients who have received solid organ or bone marrow transplants.
Post transplant lymphoproliferative disorder an update. Post transplant lymphoproliferative diseases ptld are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate solid organ or hematopoietic transplantation. Posttransplant lymphoproliferative disorder definition. Posttransplant lymphoproliferative disorderthe potential.
Late onset means that a lymphoproliferative disorder develops after twelve months. Late onset post transplant lymphoproliferative disorder ptld a cause for prolonged fever in a patient with biliary anastomotic stricture need to think beyond cholangitis. Posttransplant lymphoproliferative disorders ptlds occur after solid organ transplantation. Posttransplant lymphoproliferative disorders sciencedirect. Post transplantation lymphoproliferative disorders pptlds are defined as lymphomas that occur after transplantation fig. Posttransplant lymphoproliferative disorders ptld are a group of disorders that occur in patients who have immunodeficiency secondary to treatment with immunomodulator agents following either solid organ transplant sot or haematopoietic stem cell transplant hsct. We present a rare case of recurrent diffuse large bcell lymphoma presenting as a ptld in a heart transplant patient treated with autologous blood stem cell. Pdf posttransplant lymphoproliferative disease ptld. Late onset post transplant lymphoproliferative disorder ptld. Lymphoproliferative disorders lpds can be parsed into the following 6 categories. Posttransplant lymphoproliferative disorder gs chowdhary1, malav jhala2 abstract posttransplant lymphoproliferative disorders ptlds are lifethreatening complications of solidorgan transplantation and bone marrow transplantation leading to a high mortality. Posttransplant lymphoproliferative disorders ptld are a type of.
Barr virus infection, and disease in solid organ transplantation. Posttransplant lymphoproliferative disorder ptld is defined as a lymphoid proliferation developing in a solid organ or hematopoietic stem cell recipient and is usually intimately associated with ebv infection 1. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients. Right axial cect in the same patient demonstrates extensive retroperitoneal lymphadenopathy. Differentiation of ebvinduced posttransplant hodgkin lymphoma from. Posttransplant lymphoproliferative disease pediatric. It involves the immune system and causes white blood cells called lymphocytes to multiply out of control. Posttransplant lymphoproliferative disease ptld is a lifethreatening complication of solid organ transplantation sot.
Posttransplant lymphoproliferative disorderthe potential of. Posttransplant lymphoproliferative disorders annual. Recent insights in the pathogenesis of posttransplantation. Posttransplant lymphoproliferative disease following liver.
Post transplant lymphoproliferative disorder an update dr paul fields department of haematology guys and st thomas nhs trust 150318. These patients may develop infectious mononucleosislike lesions or polyclonal polymorphic bcell hyperplasia. The reported incidence varies depending on age, transplant type and degree of immunosuppression. Post transplant lymphoproliferative disorders ptld are a type of lymphoma that can be a result of both solid organ transplant kidney, lung, heart, liver, lung and allogeneic bone marrow or stem cell transplants cells from a donor. In this case, the clinical and radiologic presentation of ptld. In about half the patients, ptld occurs within the first year following the transplant. Posttransplant lymphoproliferative disorders ptlds are a group of conditions that involve uncontrolled proliferation of lymphoid cells as a consequence of. A rare presentation of isolated cns posttransplantation. Post transplant lymphoproliferative disorder ptld ptld is group of conditions that may happen after a transplant. A free powerpoint ppt presentation displayed as a flash slide show on id. Post transplantation lymphoproliferative disorders solidorgan and hematopoietic stemcell transplants are widely used for various lifethreatening medical disorders. Posttransplant lymphoproliferative disorders ptld oncolink. Post transplant lymphoproliferative disorders ptld are a serious complication after solid organ or allogeneic hematopoietic stem cell transplantation and include a range of diseases from benign proliferations to malignant lymphomas. We describe an 11yearold girl with epsteinbarr virus ebv reactivationpresumed posttransplant lymphoproliferative disease ptld 15 months after undergoing a deceased donor kidney.
In 1968, starzl reported the clinical observation that transplant patients are prone to develop lymphomatous growths 1. With ptld, the body makes too many lymphocytes a type of white blood cell or the lymphocytes dont act normally. However, a major drawback of the chronically immunosuppressed status of these individuals is the development of a potentially fatal posttransplant lymphoproliferative disorder ptld in up to 20% of transplant recipients. It develops in association with immunosuppression and is usually linked to epstein barr virus ebv infection. Posttransplant lymphoproliferative disorder of the pancreas. The incidence of transplantation in childhood has been steadily rising, making ptld the most common form of lymphoproliferation in childhood. Ptld occurs because the immune system of these patients is weakened to allow them to accept the newly transplanted organ or bone marrow. Treatment and prevention of posttransplant lymphoproliferative. Posttransplant lymphoproliferative disease nord national. It occurs in people whose immune systems have been intentionally suppressed due to having a solid organ transplant or hematopoietic stem cell transplant. Treatment of recurrent posttransplant lymphoproliferative. Epsteinbarr virus ebv associated posttransplant lymphoproliferative disease affects approximately 1% of renal transplant recipients, and allograft involvement is reported in 36100% of cases. Posttransplantation lymphoproliferative disorder after kidney.
1150 474 345 1024 1536 1261 525 278 557 1407 1406 768 333 300 233 951 23 919 660 602 972 874 1167 422 190 520 1239 766 1200 319 299 690 1067 268 1010 622 924 198